ZAMYL

Welcome to the Brand page for “ZAMYL”, which is offered here for Pharmaceutical preparations for the treatment of auto-immune diseases and/or oncology/hematological malignancies;.

Its status is currently believed to be active. Its class is unavailable. “ZAMYL” is believed to be currently owned by “Protein Design Labs, Inc.”


Owner:
PROTEIN DESIGN LABS, INC.
Owner Details
Description:
Pharmaceutical preparations for the treatment of auto-immune diseases and/or oncology/hematological malignancies;
Categories: PHARMACEUTICAL PREPARATIONS TREATMENT